Appropriate intraprocedural initial heparin dosing in patients undergoing catheter ablation for atrial fibrillation receiving uninterrupted non-vitamin-K antagonist oral anticoagulant treatment

Table 2 Intraprocedural ACTs and the percentage of measurements at the target ACT

ACT (s)	WG	NG110	p	WG	NG120	p	WG	NG130	p
Baseline ACT	137 ± 44	128 ± 46	0.450	137 ± 44	127 ± 45	0.352	137 ± 44	129 ± 34	0.432
15 min-ACT	324 ± 65	289 ± 51	0.015	324 ± 65	285 ± 49	0.006	324 ± 65	306 ± 51	0.182
30 min-ACT	320 ± 61	279 ± 41	0.001	320 ± 61	286 ± 26	0.003	320 ± 61	306 ± 44	0.227
45 min-ACT	302 ± 58	270 ± 39	0.010	302 ± 58	277 ± 32	0.037	302 ± 58	292 ± 37	0.389
60 min-ACT	305 ± 72	282 ± 32	0.112	305 ± 72	280 ± 28	0.089	305 ± 72	296 ± 31	0.526
75 min-ACT	299 ± 55	279 ± 47	0.179	299 ± 55	278 ± 29	0.094	299 ± 55	292 ± 26	0.555
Percentage of measurements at the target ACT (%)	63.4 ± 36.2	73.4 ± 32.6	0.179	63.4 ± 36.2	82.2 ± 23.6	0.007	63.4 ± 36.2	84.8 ± 23.7	0.003

ISSN: 1471-2261